nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—THRB—thyroid cancer	0.625	1	CbGaD
Amiodarone—CYP3A7—Sorafenib—thyroid cancer	0.0248	0.131	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0248	0.131	CbGbCtD
Amiodarone—CYP3A5—Sorafenib—thyroid cancer	0.0186	0.0985	CbGbCtD
Amiodarone—CYP2C8—Sorafenib—thyroid cancer	0.0179	0.0947	CbGbCtD
Amiodarone—CYP2C19—Sorafenib—thyroid cancer	0.015	0.0794	CbGbCtD
Amiodarone—CYP1A2—Sorafenib—thyroid cancer	0.0138	0.0733	CbGbCtD
Amiodarone—CYP2C9—Sorafenib—thyroid cancer	0.0125	0.066	CbGbCtD
Amiodarone—ABCB1—Sorafenib—thyroid cancer	0.0121	0.0641	CbGbCtD
Amiodarone—CYP3A4—Vandetanib—thyroid cancer	0.012	0.0637	CbGbCtD
Amiodarone—CYP2D6—Sorafenib—thyroid cancer	0.0114	0.0604	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—thyroid cancer	0.00734	0.0389	CbGbCtD
Amiodarone—CYP3A4—Sorafenib—thyroid cancer	0.00725	0.0384	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—thyroid cancer	0.00692	0.0366	CbGbCtD
Amiodarone—CYP3A4—Doxorubicin—thyroid cancer	0.0044	0.0233	CbGbCtD
Amiodarone—THRB—neck—thyroid cancer	0.00186	0.0953	CbGeAlD
Amiodarone—THRA—neck—thyroid cancer	0.00186	0.0953	CbGeAlD
Amiodarone—CACNA2D2—neck—thyroid cancer	0.00184	0.0943	CbGeAlD
Amiodarone—THRB—saliva-secreting gland—thyroid cancer	0.00145	0.0744	CbGeAlD
Amiodarone—THRB—thyroid gland—thyroid cancer	0.000885	0.0454	CbGeAlD
Amiodarone—THRA—thyroid gland—thyroid cancer	0.000885	0.0454	CbGeAlD
Amiodarone—CACNA2D2—thyroid gland—thyroid cancer	0.000876	0.0449	CbGeAlD
Amiodarone—THRA—head—thyroid cancer	0.000785	0.0403	CbGeAlD
Amiodarone—THRB—head—thyroid cancer	0.000785	0.0403	CbGeAlD
Amiodarone—CACNA2D2—head—thyroid cancer	0.000777	0.0398	CbGeAlD
Amiodarone—CACNA1H—thyroid gland—thyroid cancer	0.00071	0.0364	CbGeAlD
Amiodarone—SIGMAR1—saliva-secreting gland—thyroid cancer	0.000664	0.034	CbGeAlD
Amiodarone—THRB—lymph node—thyroid cancer	0.00055	0.0282	CbGeAlD
Amiodarone—THRA—lymph node—thyroid cancer	0.00055	0.0282	CbGeAlD
Amiodarone—CACNA2D2—lymph node—thyroid cancer	0.000544	0.0279	CbGeAlD
Amiodarone—SIGMAR1—trachea—thyroid cancer	0.000512	0.0263	CbGeAlD
Amiodarone—CACNA1H—lymph node—thyroid cancer	0.000441	0.0226	CbGeAlD
Amiodarone—SIGMAR1—thyroid gland—thyroid cancer	0.000405	0.0208	CbGeAlD
Amiodarone—ADRB1—head—thyroid cancer	0.000375	0.0192	CbGeAlD
Amiodarone—CYP1A1—trachea—thyroid cancer	0.000344	0.0176	CbGeAlD
Amiodarone—KCNH2—head—thyroid cancer	0.000286	0.0147	CbGeAlD
Amiodarone—CYP1A2—thyroid gland—thyroid cancer	0.000276	0.0142	CbGeAlD
Amiodarone—CYP1A1—thyroid gland—thyroid cancer	0.000272	0.014	CbGeAlD
Amiodarone—SIGMAR1—lymph node—thyroid cancer	0.000252	0.0129	CbGeAlD
Amiodarone—CYP1A1—head—thyroid cancer	0.000242	0.0124	CbGeAlD
Amiodarone—Asthenia—Vandetanib—thyroid cancer	0.000212	0.0017	CcSEcCtD
Amiodarone—Gait disturbance—Epirubicin—thyroid cancer	0.000211	0.00169	CcSEcCtD
Amiodarone—Skin discolouration—Doxorubicin—thyroid cancer	0.000211	0.00169	CcSEcCtD
Amiodarone—Coordination abnormal—Epirubicin—thyroid cancer	0.00021	0.00168	CcSEcCtD
Amiodarone—Cellulitis—Doxorubicin—thyroid cancer	0.00021	0.00168	CcSEcCtD
Amiodarone—Pruritus—Vandetanib—thyroid cancer	0.000209	0.00167	CcSEcCtD
Amiodarone—Hepatocellular injury—Epirubicin—thyroid cancer	0.000206	0.00165	CcSEcCtD
Amiodarone—Ventricular tachycardia—Epirubicin—thyroid cancer	0.000206	0.00165	CcSEcCtD
Amiodarone—Injection site reaction—Epirubicin—thyroid cancer	0.000205	0.00164	CcSEcCtD
Amiodarone—Abnormal dreams—Epirubicin—thyroid cancer	0.000204	0.00163	CcSEcCtD
Amiodarone—Dry mouth—Sorafenib—thyroid cancer	0.000203	0.00163	CcSEcCtD
Amiodarone—Dyskinesia—Doxorubicin—thyroid cancer	0.000203	0.00163	CcSEcCtD
Amiodarone—Diarrhoea—Vandetanib—thyroid cancer	0.000202	0.00162	CcSEcCtD
Amiodarone—Salivary hypersecretion—Epirubicin—thyroid cancer	0.0002	0.00161	CcSEcCtD
Amiodarone—KCNH2—lymph node—thyroid cancer	0.0002	0.0103	CbGeAlD
Amiodarone—Anaphylactic shock—Sorafenib—thyroid cancer	0.000199	0.0016	CcSEcCtD
Amiodarone—Infection—Sorafenib—thyroid cancer	0.000198	0.00159	CcSEcCtD
Amiodarone—Skin exfoliation—Epirubicin—thyroid cancer	0.000197	0.00158	CcSEcCtD
Amiodarone—Atrioventricular block—Doxorubicin—thyroid cancer	0.000197	0.00158	CcSEcCtD
Amiodarone—Inflammation—Doxorubicin—thyroid cancer	0.000197	0.00158	CcSEcCtD
Amiodarone—Shock—Sorafenib—thyroid cancer	0.000196	0.00157	CcSEcCtD
Amiodarone—Gait disturbance—Doxorubicin—thyroid cancer	0.000196	0.00157	CcSEcCtD
Amiodarone—Dizziness—Vandetanib—thyroid cancer	0.000195	0.00156	CcSEcCtD
Amiodarone—Thrombocytopenia—Sorafenib—thyroid cancer	0.000195	0.00156	CcSEcCtD
Amiodarone—Coordination abnormal—Doxorubicin—thyroid cancer	0.000194	0.00156	CcSEcCtD
Amiodarone—Aplastic anaemia—Epirubicin—thyroid cancer	0.000194	0.00155	CcSEcCtD
Amiodarone—Neuropathy—Epirubicin—thyroid cancer	0.000194	0.00155	CcSEcCtD
Amiodarone—Skin disorder—Sorafenib—thyroid cancer	0.000194	0.00155	CcSEcCtD
Amiodarone—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.000191	0.00153	CcSEcCtD
Amiodarone—Hepatocellular injury—Doxorubicin—thyroid cancer	0.000191	0.00153	CcSEcCtD
Amiodarone—Dry eye—Epirubicin—thyroid cancer	0.000191	0.00153	CcSEcCtD
Amiodarone—Anorexia—Sorafenib—thyroid cancer	0.00019	0.00152	CcSEcCtD
Amiodarone—Injection site reaction—Doxorubicin—thyroid cancer	0.00019	0.00152	CcSEcCtD
Amiodarone—Abnormal dreams—Doxorubicin—thyroid cancer	0.000189	0.00151	CcSEcCtD
Amiodarone—Vomiting—Vandetanib—thyroid cancer	0.000188	0.0015	CcSEcCtD
Amiodarone—Ecchymosis—Epirubicin—thyroid cancer	0.000187	0.00149	CcSEcCtD
Amiodarone—Rash—Vandetanib—thyroid cancer	0.000186	0.00149	CcSEcCtD
Amiodarone—Dermatitis—Vandetanib—thyroid cancer	0.000186	0.00149	CcSEcCtD
Amiodarone—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000185	0.00149	CcSEcCtD
Amiodarone—Headache—Vandetanib—thyroid cancer	0.000185	0.00148	CcSEcCtD
Amiodarone—Pulmonary oedema—Epirubicin—thyroid cancer	0.000184	0.00147	CcSEcCtD
Amiodarone—Skin exfoliation—Doxorubicin—thyroid cancer	0.000182	0.00146	CcSEcCtD
Amiodarone—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000179	0.00144	CcSEcCtD
Amiodarone—Neuropathy—Doxorubicin—thyroid cancer	0.000179	0.00144	CcSEcCtD
Amiodarone—ABCB1—trachea—thyroid cancer	0.000179	0.00917	CbGeAlD
Amiodarone—Dyspnoea—Sorafenib—thyroid cancer	0.000178	0.00142	CcSEcCtD
Amiodarone—Dry eye—Doxorubicin—thyroid cancer	0.000176	0.00141	CcSEcCtD
Amiodarone—Nausea—Vandetanib—thyroid cancer	0.000175	0.0014	CcSEcCtD
Amiodarone—Dyspepsia—Sorafenib—thyroid cancer	0.000175	0.0014	CcSEcCtD
Amiodarone—CYP2D6—head—thyroid cancer	0.000175	0.00894	CbGeAlD
Amiodarone—Phlebitis—Epirubicin—thyroid cancer	0.000174	0.00139	CcSEcCtD
Amiodarone—Decreased appetite—Sorafenib—thyroid cancer	0.000173	0.00139	CcSEcCtD
Amiodarone—Thrombophlebitis—Epirubicin—thyroid cancer	0.000173	0.00139	CcSEcCtD
Amiodarone—Ecchymosis—Doxorubicin—thyroid cancer	0.000173	0.00138	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000172	0.00138	CcSEcCtD
Amiodarone—Fatigue—Sorafenib—thyroid cancer	0.000172	0.00138	CcSEcCtD
Amiodarone—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000171	0.00137	CcSEcCtD
Amiodarone—Photosensitivity—Epirubicin—thyroid cancer	0.000171	0.00137	CcSEcCtD
Amiodarone—Constipation—Sorafenib—thyroid cancer	0.00017	0.00136	CcSEcCtD
Amiodarone—Pain—Sorafenib—thyroid cancer	0.00017	0.00136	CcSEcCtD
Amiodarone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00017	0.00136	CcSEcCtD
Amiodarone—CYP1A1—lymph node—thyroid cancer	0.000169	0.00867	CbGeAlD
Amiodarone—Eczema—Epirubicin—thyroid cancer	0.000167	0.00134	CcSEcCtD
Amiodarone—Hepatic failure—Epirubicin—thyroid cancer	0.000167	0.00134	CcSEcCtD
Amiodarone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000165	0.00132	CcSEcCtD
Amiodarone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000163	0.0013	CcSEcCtD
Amiodarone—Renal failure acute—Epirubicin—thyroid cancer	0.000162	0.0013	CcSEcCtD
Amiodarone—Phlebitis—Doxorubicin—thyroid cancer	0.000161	0.00129	CcSEcCtD
Amiodarone—Hot flush—Epirubicin—thyroid cancer	0.00016	0.00128	CcSEcCtD
Amiodarone—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00016	0.00128	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000159	0.00127	CcSEcCtD
Amiodarone—Menopausal symptoms—Epirubicin—thyroid cancer	0.000159	0.00127	CcSEcCtD
Amiodarone—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000159	0.00127	CcSEcCtD
Amiodarone—Urticaria—Sorafenib—thyroid cancer	0.000158	0.00127	CcSEcCtD
Amiodarone—Photosensitivity—Doxorubicin—thyroid cancer	0.000158	0.00126	CcSEcCtD
Amiodarone—Abdominal pain—Sorafenib—thyroid cancer	0.000158	0.00126	CcSEcCtD
Amiodarone—Body temperature increased—Sorafenib—thyroid cancer	0.000158	0.00126	CcSEcCtD
Amiodarone—Renal impairment—Epirubicin—thyroid cancer	0.000157	0.00126	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000155	0.00124	CcSEcCtD
Amiodarone—Eczema—Doxorubicin—thyroid cancer	0.000154	0.00124	CcSEcCtD
Amiodarone—Hepatic failure—Doxorubicin—thyroid cancer	0.000154	0.00124	CcSEcCtD
Amiodarone—Cardiac failure—Epirubicin—thyroid cancer	0.000154	0.00123	CcSEcCtD
Amiodarone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000153	0.00122	CcSEcCtD
Amiodarone—Renal failure acute—Doxorubicin—thyroid cancer	0.00015	0.0012	CcSEcCtD
Amiodarone—Hot flush—Doxorubicin—thyroid cancer	0.000148	0.00119	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000147	0.00118	CcSEcCtD
Amiodarone—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000147	0.00118	CcSEcCtD
Amiodarone—Hypersensitivity—Sorafenib—thyroid cancer	0.000147	0.00118	CcSEcCtD
Amiodarone—Renal impairment—Doxorubicin—thyroid cancer	0.000146	0.00117	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000143	0.00115	CcSEcCtD
Amiodarone—Asthenia—Sorafenib—thyroid cancer	0.000143	0.00114	CcSEcCtD
Amiodarone—Cardiac arrest—Epirubicin—thyroid cancer	0.000142	0.00114	CcSEcCtD
Amiodarone—Cardiac failure—Doxorubicin—thyroid cancer	0.000142	0.00114	CcSEcCtD
Amiodarone—ABCB1—thyroid gland—thyroid cancer	0.000141	0.00725	CbGeAlD
Amiodarone—Pruritus—Sorafenib—thyroid cancer	0.000141	0.00113	CcSEcCtD
Amiodarone—Ataxia—Epirubicin—thyroid cancer	0.000141	0.00113	CcSEcCtD
Amiodarone—Liver function test abnormal—Epirubicin—thyroid cancer	0.000138	0.00111	CcSEcCtD
Amiodarone—Diarrhoea—Sorafenib—thyroid cancer	0.000136	0.00109	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000135	0.00108	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000135	0.00108	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000132	0.00106	CcSEcCtD
Amiodarone—Muscular weakness—Epirubicin—thyroid cancer	0.000132	0.00106	CcSEcCtD
Amiodarone—Cardiac arrest—Doxorubicin—thyroid cancer	0.000132	0.00106	CcSEcCtD
Amiodarone—Dizziness—Sorafenib—thyroid cancer	0.000132	0.00106	CcSEcCtD
Amiodarone—Ataxia—Doxorubicin—thyroid cancer	0.00013	0.00104	CcSEcCtD
Amiodarone—Eosinophilia—Epirubicin—thyroid cancer	0.000128	0.00103	CcSEcCtD
Amiodarone—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000128	0.00102	CcSEcCtD
Amiodarone—Pancreatitis—Epirubicin—thyroid cancer	0.000127	0.00102	CcSEcCtD
Amiodarone—Vomiting—Sorafenib—thyroid cancer	0.000127	0.00101	CcSEcCtD
Amiodarone—Angina pectoris—Epirubicin—thyroid cancer	0.000126	0.00101	CcSEcCtD
Amiodarone—Rash—Sorafenib—thyroid cancer	0.000126	0.00101	CcSEcCtD
Amiodarone—Dermatitis—Sorafenib—thyroid cancer	0.000126	0.00101	CcSEcCtD
Amiodarone—ABCB1—head—thyroid cancer	0.000126	0.00643	CbGeAlD
Amiodarone—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000125	0.001	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000125	0.001	CcSEcCtD
Amiodarone—Headache—Sorafenib—thyroid cancer	0.000125	0.001	CcSEcCtD
Amiodarone—Pancytopenia—Epirubicin—thyroid cancer	0.000123	0.000985	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—thyroid cancer	0.000122	0.000979	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000122	0.000979	CcSEcCtD
Amiodarone—Neutropenia—Epirubicin—thyroid cancer	0.000121	0.00097	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—thyroid cancer	0.000119	0.00095	CcSEcCtD
Amiodarone—Nausea—Sorafenib—thyroid cancer	0.000118	0.000948	CcSEcCtD
Amiodarone—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000118	0.000947	CcSEcCtD
Amiodarone—Weight increased—Epirubicin—thyroid cancer	0.000118	0.000944	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—thyroid cancer	0.000117	0.000941	CcSEcCtD
Amiodarone—Weight decreased—Epirubicin—thyroid cancer	0.000117	0.000938	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—thyroid cancer	0.000117	0.000935	CcSEcCtD
Amiodarone—Pneumonia—Epirubicin—thyroid cancer	0.000116	0.00093	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000114	0.000917	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—thyroid cancer	0.000114	0.000911	CcSEcCtD
Amiodarone—Renal failure—Epirubicin—thyroid cancer	0.000114	0.000909	CcSEcCtD
Amiodarone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000113	0.000906	CcSEcCtD
Amiodarone—Jaundice—Epirubicin—thyroid cancer	0.000113	0.000901	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—thyroid cancer	0.000112	0.000897	CcSEcCtD
Amiodarone—Sweating—Epirubicin—thyroid cancer	0.000111	0.000886	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000109	0.000876	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—thyroid cancer	0.000109	0.000873	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—thyroid cancer	0.000108	0.000868	CcSEcCtD
Amiodarone—Agranulocytosis—Epirubicin—thyroid cancer	0.000108	0.000863	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—thyroid cancer	0.000107	0.00086	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000106	0.000848	CcSEcCtD
Amiodarone—Bradycardia—Epirubicin—thyroid cancer	0.000106	0.000845	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—thyroid cancer	0.000105	0.000841	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000105	0.000839	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—thyroid cancer	0.000104	0.000834	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—thyroid cancer	0.000104	0.00083	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—thyroid cancer	0.000102	0.00082	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—thyroid cancer	9.99e-05	0.0008	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—thyroid cancer	9.97e-05	0.000798	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—thyroid cancer	9.8e-05	0.000785	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—thyroid cancer	9.76e-05	0.000782	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—thyroid cancer	9.66e-05	0.000774	CcSEcCtD
Amiodarone—Flushing—Epirubicin—thyroid cancer	9.62e-05	0.00077	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—thyroid cancer	9.59e-05	0.000768	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—thyroid cancer	9.26e-05	0.000741	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—thyroid cancer	9.24e-05	0.00074	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—thyroid cancer	9.16e-05	0.000733	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—thyroid cancer	9.07e-05	0.000726	CcSEcCtD
Amiodarone—Erythema—Epirubicin—thyroid cancer	9.02e-05	0.000723	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—thyroid cancer	8.94e-05	0.000716	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—thyroid cancer	8.9e-05	0.000713	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—thyroid cancer	8.84e-05	0.000708	CcSEcCtD
Amiodarone—ABCB1—lymph node—thyroid cancer	8.79e-05	0.00451	CbGeAlD
Amiodarone—Back pain—Epirubicin—thyroid cancer	8.73e-05	0.000699	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—thyroid cancer	8.57e-05	0.000686	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—thyroid cancer	8.5e-05	0.000681	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—thyroid cancer	8.48e-05	0.000679	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—thyroid cancer	8.37e-05	0.00067	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—thyroid cancer	8.35e-05	0.000669	CcSEcCtD
Amiodarone—Agitation—Epirubicin—thyroid cancer	8.29e-05	0.000664	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—thyroid cancer	8.18e-05	0.000655	CcSEcCtD
Amiodarone—Malaise—Epirubicin—thyroid cancer	8.14e-05	0.000652	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—thyroid cancer	8.11e-05	0.000649	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—thyroid cancer	8.08e-05	0.000647	CcSEcCtD
Amiodarone—Cough—Epirubicin—thyroid cancer	7.87e-05	0.00063	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—thyroid cancer	7.87e-05	0.00063	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—thyroid cancer	7.75e-05	0.00062	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—thyroid cancer	7.67e-05	0.000614	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—thyroid cancer	7.66e-05	0.000613	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—thyroid cancer	7.59e-05	0.000608	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—thyroid cancer	7.53e-05	0.000603	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—thyroid cancer	7.51e-05	0.000602	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—thyroid cancer	7.5e-05	0.000601	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—thyroid cancer	7.43e-05	0.000595	CcSEcCtD
Amiodarone—Oedema—Epirubicin—thyroid cancer	7.36e-05	0.00059	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—thyroid cancer	7.36e-05	0.00059	CcSEcCtD
Amiodarone—Infection—Epirubicin—thyroid cancer	7.32e-05	0.000586	CcSEcCtD
Amiodarone—Cough—Doxorubicin—thyroid cancer	7.29e-05	0.000583	CcSEcCtD
Amiodarone—Shock—Epirubicin—thyroid cancer	7.25e-05	0.00058	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—thyroid cancer	7.21e-05	0.000577	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—thyroid cancer	7.19e-05	0.000576	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—thyroid cancer	7.15e-05	0.000573	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—thyroid cancer	7.12e-05	0.00057	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—thyroid cancer	7.08e-05	0.000567	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—thyroid cancer	7.02e-05	0.000562	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—thyroid cancer	7.02e-05	0.000562	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—thyroid cancer	6.95e-05	0.000557	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—thyroid cancer	6.88e-05	0.000551	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—thyroid cancer	6.87e-05	0.00055	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—thyroid cancer	6.81e-05	0.000546	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—thyroid cancer	6.81e-05	0.000546	CcSEcCtD
Amiodarone—Infection—Doxorubicin—thyroid cancer	6.77e-05	0.000542	CcSEcCtD
Amiodarone—Shock—Doxorubicin—thyroid cancer	6.7e-05	0.000537	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—thyroid cancer	6.67e-05	0.000534	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—thyroid cancer	6.66e-05	0.000533	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—thyroid cancer	6.65e-05	0.000533	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—thyroid cancer	6.62e-05	0.00053	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—thyroid cancer	6.61e-05	0.000529	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—thyroid cancer	6.59e-05	0.000527	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—thyroid cancer	6.57e-05	0.000526	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—thyroid cancer	6.5e-05	0.00052	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—thyroid cancer	6.48e-05	0.000519	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—thyroid cancer	6.4e-05	0.000513	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—thyroid cancer	6.37e-05	0.00051	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—thyroid cancer	6.36e-05	0.000509	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—thyroid cancer	6.35e-05	0.000508	CcSEcCtD
Amiodarone—Pain—Epirubicin—thyroid cancer	6.3e-05	0.000504	CcSEcCtD
Amiodarone—Constipation—Epirubicin—thyroid cancer	6.3e-05	0.000504	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—thyroid cancer	6.16e-05	0.000493	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—thyroid cancer	6.12e-05	0.00049	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—thyroid cancer	6.08e-05	0.000486	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—thyroid cancer	6.07e-05	0.000486	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—thyroid cancer	6.02e-05	0.000482	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—thyroid cancer	6e-05	0.00048	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—thyroid cancer	5.92e-05	0.000474	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	5.88e-05	0.000471	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—thyroid cancer	5.87e-05	0.00047	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—thyroid cancer	5.85e-05	0.000468	CcSEcCtD
Amiodarone—Pain—Doxorubicin—thyroid cancer	5.83e-05	0.000467	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—thyroid cancer	5.83e-05	0.000467	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—thyroid cancer	5.82e-05	0.000466	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—thyroid cancer	5.82e-05	0.000466	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—thyroid cancer	5.62e-05	0.00045	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—thyroid cancer	5.57e-05	0.000446	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—thyroid cancer	5.43e-05	0.000434	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—thyroid cancer	5.41e-05	0.000433	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—thyroid cancer	5.39e-05	0.000431	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—thyroid cancer	5.39e-05	0.000431	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—thyroid cancer	5.28e-05	0.000423	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—thyroid cancer	5.21e-05	0.000417	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—thyroid cancer	5.04e-05	0.000403	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—thyroid cancer	5.02e-05	0.000402	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—thyroid cancer	4.89e-05	0.000391	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—thyroid cancer	4.87e-05	0.00039	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—thyroid cancer	4.82e-05	0.000386	CcSEcCtD
Amiodarone—Vomiting—Epirubicin—thyroid cancer	4.68e-05	0.000375	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—thyroid cancer	4.66e-05	0.000373	CcSEcCtD
Amiodarone—Rash—Epirubicin—thyroid cancer	4.64e-05	0.000372	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—thyroid cancer	4.64e-05	0.000371	CcSEcCtD
Amiodarone—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	4.63e-05	0.00111	CbGpPWpGaD
Amiodarone—Headache—Epirubicin—thyroid cancer	4.61e-05	0.000369	CcSEcCtD
Amiodarone—CYP2A6—Metabolism—MINPP1—thyroid cancer	4.58e-05	0.0011	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—PTCH1—thyroid cancer	4.55e-05	0.00109	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.55e-05	0.00109	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—BRAF—thyroid cancer	4.55e-05	0.00109	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.53e-05	0.00108	CbGpPWpGaD
Amiodarone—Dizziness—Doxorubicin—thyroid cancer	4.51e-05	0.000361	CcSEcCtD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	4.48e-05	0.00107	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	4.44e-05	0.00106	CbGpPWpGaD
Amiodarone—Nausea—Epirubicin—thyroid cancer	4.37e-05	0.00035	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—thyroid cancer	4.33e-05	0.000347	CcSEcCtD
Amiodarone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.3e-05	0.00103	CbGpPWpGaD
Amiodarone—Rash—Doxorubicin—thyroid cancer	4.3e-05	0.000344	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—thyroid cancer	4.29e-05	0.000344	CcSEcCtD
Amiodarone—CACNA1H—Axon guidance—NRAS—thyroid cancer	4.27e-05	0.00102	CbGpPWpGaD
Amiodarone—Headache—Doxorubicin—thyroid cancer	4.27e-05	0.000342	CcSEcCtD
Amiodarone—CYP2C8—Biological oxidations—RXRA—thyroid cancer	4.26e-05	0.00102	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—NDUFA13—thyroid cancer	4.25e-05	0.00102	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	4.23e-05	0.00101	CbGpPWpGaD
Amiodarone—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	4.19e-05	0.001	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—SST—thyroid cancer	4.16e-05	0.000996	CbGpPWpGaD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	4.11e-05	0.000982	CbGpPWpGaD
Amiodarone—Nausea—Doxorubicin—thyroid cancer	4.05e-05	0.000324	CcSEcCtD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.04e-05	0.000967	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CALCA—thyroid cancer	4.01e-05	0.000959	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CHST14—thyroid cancer	4e-05	0.000956	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—SLC5A5—thyroid cancer	3.97e-05	0.000949	CbGpPWpGaD
Amiodarone—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	3.95e-05	0.000946	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NDUFA13—thyroid cancer	3.9e-05	0.000932	CbGpPWpGaD
Amiodarone—CYP2C19—Biological oxidations—RXRA—thyroid cancer	3.8e-05	0.00091	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	3.77e-05	0.000903	CbGpPWpGaD
Amiodarone—CACNA2D2—Neuronal System—HRAS—thyroid cancer	3.74e-05	0.000895	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.69e-05	0.000882	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—KRAS—thyroid cancer	3.68e-05	0.00088	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CHST14—thyroid cancer	3.66e-05	0.000876	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—MINPP1—thyroid cancer	3.61e-05	0.000864	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CALCB—thyroid cancer	3.51e-05	0.000839	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—RXRA—thyroid cancer	3.5e-05	0.000837	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—PPARG—thyroid cancer	3.47e-05	0.000831	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—PPARG—thyroid cancer	3.47e-05	0.000831	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—RXRA—thyroid cancer	3.47e-05	0.000829	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—MINPP1—thyroid cancer	3.41e-05	0.000817	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	3.41e-05	0.000816	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—RXRA—thyroid cancer	3.33e-05	0.000797	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TRIM33—thyroid cancer	3.32e-05	0.000795	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	3.29e-05	0.000787	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—HPGD—thyroid cancer	3.22e-05	0.00077	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.15e-05	0.000753	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—MINPP1—thyroid cancer	3.13e-05	0.000749	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—HRAS—thyroid cancer	3.13e-05	0.000748	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NDUFA13—thyroid cancer	3.07e-05	0.000735	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—NRAS—thyroid cancer	3.05e-05	0.00073	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—TSHR—thyroid cancer	3.03e-05	0.000724	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—RXRA—thyroid cancer	2.96e-05	0.000709	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PPARG—thyroid cancer	2.95e-05	0.000706	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—HPGD—thyroid cancer	2.95e-05	0.000706	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NDUFA13—thyroid cancer	2.9e-05	0.000694	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CHST14—thyroid cancer	2.89e-05	0.000691	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	2.83e-05	0.000677	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	2.83e-05	0.000677	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—MINPP1—thyroid cancer	2.79e-05	0.000668	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—TSHR—thyroid cancer	2.75e-05	0.000657	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CHST14—thyroid cancer	2.73e-05	0.000653	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—MINPP1—thyroid cancer	2.73e-05	0.000652	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PRKAR1A—thyroid cancer	2.7e-05	0.000647	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NDUFA13—thyroid cancer	2.66e-05	0.000637	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—KRAS—thyroid cancer	2.62e-05	0.000628	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—MINPP1—thyroid cancer	2.57e-05	0.000615	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—MINPP1—thyroid cancer	2.55e-05	0.000609	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CHST14—thyroid cancer	2.5e-05	0.000598	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	2.41e-05	0.000575	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NDUFA13—thyroid cancer	2.37e-05	0.000568	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—SST—thyroid cancer	2.35e-05	0.000563	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PTCH1—thyroid cancer	2.34e-05	0.000559	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—HPGD—thyroid cancer	2.33e-05	0.000557	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PTGS2—thyroid cancer	2.32e-05	0.000556	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NDUFA13—thyroid cancer	2.32e-05	0.000555	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.29e-05	0.000547	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CALCA—thyroid cancer	2.26e-05	0.000542	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CHST14—thyroid cancer	2.23e-05	0.000534	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—HRAS—thyroid cancer	2.23e-05	0.000534	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TCF7L1—thyroid cancer	2.22e-05	0.00053	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—HPGD—thyroid cancer	2.2e-05	0.000526	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NDUFA13—thyroid cancer	2.18e-05	0.000523	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CHST14—thyroid cancer	2.18e-05	0.000521	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—MINPP1—thyroid cancer	2.18e-05	0.000521	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.17e-05	0.000518	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.15e-05	0.000515	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.15e-05	0.000515	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—SST—thyroid cancer	2.14e-05	0.000511	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.12e-05	0.000507	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PPARG—thyroid cancer	2.1e-05	0.000503	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—HRAS—thyroid cancer	2.09e-05	0.0005	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CALCA—thyroid cancer	2.06e-05	0.000492	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CHST14—thyroid cancer	2.05e-05	0.000491	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CHST14—thyroid cancer	2.04e-05	0.000487	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PTEN—thyroid cancer	2.03e-05	0.000485	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—HPGD—thyroid cancer	2.02e-05	0.000482	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.99e-05	0.000477	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—AKT1—thyroid cancer	1.97e-05	0.000471	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CDK1—thyroid cancer	1.86e-05	0.000445	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NDUFA13—thyroid cancer	1.85e-05	0.000443	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—TPR—thyroid cancer	1.85e-05	0.000443	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	1.82e-05	0.000435	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—HPGD—thyroid cancer	1.8e-05	0.000431	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.78e-05	0.000427	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—HPGD—thyroid cancer	1.76e-05	0.00042	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CHST14—thyroid cancer	1.74e-05	0.000416	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—TPR—thyroid cancer	1.7e-05	0.000406	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.69e-05	0.000405	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.68e-05	0.000402	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	1.67e-05	0.000399	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—HPGD—thyroid cancer	1.66e-05	0.000396	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PTGS2—thyroid cancer	1.65e-05	0.000396	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—HPGD—thyroid cancer	1.64e-05	0.000393	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.64e-05	0.000391	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TSHR—thyroid cancer	1.62e-05	0.000388	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.61e-05	0.000386	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PRKAR1A—thyroid cancer	1.6e-05	0.000382	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.53e-05	0.000366	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MEN1—thyroid cancer	1.53e-05	0.000365	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.48e-05	0.000354	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.46e-05	0.000349	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PTEN—thyroid cancer	1.44e-05	0.000345	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.43e-05	0.000342	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HPGD—thyroid cancer	1.4e-05	0.000336	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.38e-05	0.000331	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTCH1—thyroid cancer	1.38e-05	0.00033	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—AKT1—thyroid cancer	1.37e-05	0.000328	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—AKT1—thyroid cancer	1.37e-05	0.000328	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.35e-05	0.000324	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CHST14—thyroid cancer	1.34e-05	0.000321	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TPR—thyroid cancer	1.34e-05	0.00032	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.33e-05	0.000318	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.32e-05	0.000315	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—SLC5A5—thyroid cancer	1.27e-05	0.000304	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TPR—thyroid cancer	1.26e-05	0.000302	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SST—thyroid cancer	1.26e-05	0.000302	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	1.24e-05	0.000297	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CALCA—thyroid cancer	1.21e-05	0.000291	CbGpPWpGaD
Amiodarone—EBP—Metabolism—AKT1—thyroid cancer	1.17e-05	0.000279	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—RXRA—thyroid cancer	1.16e-05	0.000278	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TPR—thyroid cancer	1.16e-05	0.000277	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.14e-05	0.000273	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.14e-05	0.000272	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.14e-05	0.000272	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.13e-05	0.000269	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDK1—thyroid cancer	1.1e-05	0.000263	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HPGD—thyroid cancer	1.08e-05	0.000259	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—RXRA—thyroid cancer	1.07e-05	0.000255	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TPR—thyroid cancer	1.03e-05	0.000247	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.03e-05	0.000247	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.02e-05	0.000243	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TPR—thyroid cancer	1.01e-05	0.000241	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.01e-05	0.000241	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1e-05	0.000239	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	9.93e-06	0.000237	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TPR—thyroid cancer	9.51e-06	0.000227	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SLC5A5—thyroid cancer	9.46e-06	0.000226	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TPR—thyroid cancer	9.43e-06	0.000226	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	9.35e-06	0.000224	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	9.27e-06	0.000222	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.22e-06	0.000221	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.86e-06	0.000212	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NRG1—thyroid cancer	8.83e-06	0.000211	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SLC5A5—thyroid cancer	8.67e-06	0.000207	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	8.52e-06	0.000204	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—RXRA—thyroid cancer	8.41e-06	0.000201	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.4e-06	0.000201	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—AKT1—thyroid cancer	8.32e-06	0.000199	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.12e-06	0.000194	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TPR—thyroid cancer	8.05e-06	0.000193	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—RXRA—thyroid cancer	7.95e-06	0.00019	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TERT—thyroid cancer	7.93e-06	0.00019	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	7.92e-06	0.00019	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC5A5—thyroid cancer	7.74e-06	0.000185	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.73e-06	0.000185	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HIF1A—thyroid cancer	7.58e-06	0.000181	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC5A5—thyroid cancer	7.55e-06	0.000181	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PPARG—thyroid cancer	7.35e-06	0.000176	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—RXRA—thyroid cancer	7.28e-06	0.000174	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.25e-06	0.000173	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.18e-06	0.000172	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC5A5—thyroid cancer	7.12e-06	0.00017	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.08e-06	0.000169	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC5A5—thyroid cancer	7.06e-06	0.000169	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PPARG—thyroid cancer	6.73e-06	0.000161	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—NRAS—thyroid cancer	6.68e-06	0.00016	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.61e-06	0.000158	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—RXRA—thyroid cancer	6.5e-06	0.000156	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—RXRA—thyroid cancer	6.35e-06	0.000152	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.32e-06	0.000151	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—BRAF—thyroid cancer	6.28e-06	0.00015	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TPR—thyroid cancer	6.22e-06	0.000149	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	6.12e-06	0.000146	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC5A5—thyroid cancer	6.03e-06	0.000144	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—RXRA—thyroid cancer	5.98e-06	0.000143	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—RXRA—thyroid cancer	5.93e-06	0.000142	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—thyroid cancer	5.78e-06	0.000138	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.77e-06	0.000138	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—thyroid cancer	5.75e-06	0.000137	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.65e-06	0.000135	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPARG—thyroid cancer	5.31e-06	0.000127	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—thyroid cancer	5.3e-06	0.000127	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—RXRA—thyroid cancer	5.07e-06	0.000121	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—thyroid cancer	5.04e-06	0.000121	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPARG—thyroid cancer	5.02e-06	0.00012	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.93e-06	0.000118	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—thyroid cancer	4.89e-06	0.000117	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—thyroid cancer	4.75e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	4.65e-06	0.000111	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—thyroid cancer	4.62e-06	0.000111	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARG—thyroid cancer	4.6e-06	0.00011	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—thyroid cancer	4.58e-06	0.00011	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—thyroid cancer	4.42e-06	0.000106	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—thyroid cancer	4.31e-06	0.000103	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—thyroid cancer	4.18e-06	9.99e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARG—thyroid cancer	4.11e-06	9.82e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARG—thyroid cancer	4.01e-06	9.59e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—thyroid cancer	3.95e-06	9.44e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NRAS—thyroid cancer	3.94e-06	9.44e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—RXRA—thyroid cancer	3.91e-06	9.35e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARG—thyroid cancer	3.78e-06	9.03e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARG—thyroid cancer	3.74e-06	8.95e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—thyroid cancer	3.64e-06	8.72e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—thyroid cancer	3.62e-06	8.66e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—thyroid cancer	3.44e-06	8.23e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—thyroid cancer	3.4e-06	8.12e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—thyroid cancer	3.23e-06	7.73e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARG—thyroid cancer	3.2e-06	7.65e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—thyroid cancer	3.16e-06	7.55e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—thyroid cancer	3.15e-06	7.54e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—thyroid cancer	3.02e-06	7.22e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—thyroid cancer	2.97e-06	7.11e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—thyroid cancer	2.94e-06	7.04e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—thyroid cancer	2.9e-06	6.95e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—thyroid cancer	2.89e-06	6.9e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—thyroid cancer	2.82e-06	6.74e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—thyroid cancer	2.75e-06	6.58e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—thyroid cancer	2.66e-06	6.37e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—thyroid cancer	2.59e-06	6.2e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—thyroid cancer	2.57e-06	6.14e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—thyroid cancer	2.55e-06	6.1e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—thyroid cancer	2.52e-06	6.02e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARG—thyroid cancer	2.47e-06	5.91e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—thyroid cancer	2.19e-06	5.25e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—thyroid cancer	2.1e-06	5.02e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—thyroid cancer	1.98e-06	4.75e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.94e-06	4.65e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—thyroid cancer	1.82e-06	4.35e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—thyroid cancer	1.69e-06	4.05e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—thyroid cancer	1.62e-06	3.88e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—thyroid cancer	1.58e-06	3.79e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—thyroid cancer	1.49e-06	3.57e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—thyroid cancer	1.48e-06	3.54e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—thyroid cancer	1.26e-06	3.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—thyroid cancer	9.76e-07	2.34e-05	CbGpPWpGaD
